Evidence map›Paper›PMID 28167832›Full record

ArticleLeukemia2017

Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach.

A Coppe, E I Andersson, A Binatti, V R Gasparini, S Bortoluzzi, M Clemente, M Herling, J Maciejewski, S Mustjoki, S Bortoluzzi

Abstract read
In one paragraph

Article in Leukemia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Genetic alterations in mature B- and T-cell lymphomas - a practical guide to WHO-HAEM5.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. SomaticHaematologica · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Cancers · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

A CoppeDepartment of Molecular Medicine, University of Padova, Padova, Italy.
E I AnderssonHematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
A BinattiDepartment of Molecular Medicine, University of Padova, Padova, Italy.
V R GaspariniDepartment of Molecular Medicine, University of Padova, Padova, Italy.
S BortoluzziDepartment of Molecular Medicine, University of Padova, Padova, Italy.
M ClementeDepartment of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
M HerlingLaboratory of Lymphocyte Signaling and Oncoproteome, CECAD, Cologne University, Cologne, Germany.
J MaciejewskiDepartment of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
S MustjokiHematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
S BortoluzziDepartment of Molecular Medicine, University of Padova, Padova, Italy.

Funding

European Research Council 647355
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GenomicsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansLeukemia, Large Granular LymphocyticTranscription FactorsTranscription Factors

Identifiers

PMID28167832
PMCPMC5419584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.